Dr. Sears on Microbiota in Colon Cancer

Video

In Partnership With:

Cynthia L. Sears, MD, professor of Medicine, at John Hopkins University School of Medicine, member of the Bloomberg-Kimmel Institute for Cancer Immunotherapy, discusses microbiota in patients with colon cancer.

Cynthia L. Sears, MD, professor of Medicine, at Johns Hopkins University School of Medicine, member of the Bloomberg-Kimmel Institute for Cancer Immunotherapy, discusses microbiota in patients with colon cancer.

When single organisms, particularly bacteria such as e-coli or enterotoxigenic bacteroides fragilis, are added to a complex microbiota in a mouse, you increase the numbers of tumors in the colon compared with the background mouse, says Sears.

At a minimum, studying those models helps experts in the field to better understand the mechanisms by which bacteria may be procarcinogenic and allows for the ability to look at humans who have those organisms and see if any of those mechanisms transfer there, explains Sears.

Related Videos
Rohan Garje, MD, chief, Genitourinary Medical Oncology, Baptist Health Miami Cancer Institute
Changchun Deng, MD, PhD, associate professor, hematology/oncology, University Hospitals Seidman Cancer Center; member, Immune Oncology Program, Case Comprehensive Cancer Center
Jaime R. Merchán, MD
Erin Frances Cobain, MD
Mark D. Tyson, II, MD, MPH
Michael Iglesia, MD, PhD
Sundar Jagannath, MBBS
Jonathan E. Rosenberg, MD
Núria Agustí Garcia, MD
Erin Frances Cobain, MD